IDEAS home Printed from https://ideas.repec.org/h/zbw/eschap/273742.html
   My bibliography  Save this book chapter

Innovations Through Mergers and Acquisitions in the Pharmaceutical Sector

In: Technological Innovations for Sustainability and Business Growth

Author

Listed:
  • Wajid, Abdul
  • Khan, Kashif Hasan
  • Handa, Harish

Abstract

Pharmaceutical firms have a noteworthy contribution in SDGs (Sustainable development goals). Their unceasing innovation of low-cost medicines and discovery of lifesaving drugs can assist in achieving the SDG 3 (good health and well-being). Having gone through the M&A scenario in the global pharmaceutical industry and the amount disbursed on R&D, the authors tried to find answers to a few important questions to understand whether these activities are in line to achieve global goals i.e. first, does Merger and Acquisition M&A in pharmaceutical sector increase innovations? Second, how can companies fully utilize M&A activities to increase innovation in the pharmaceutical sector? Third, is there any association between R&D expenditures and innovation outcome? We theoretically analyze and consolidate academic research on how M&A activities support innovation in the pharmaceutical industry. The present chapter also tried to unveil the association between R&D expenditures and the firm innovation as measured by the number of patent applications by selected Indian pharmaceutical firms.

Suggested Citation

  • Wajid, Abdul & Khan, Kashif Hasan & Handa, Harish, 2022. "Innovations Through Mergers and Acquisitions in the Pharmaceutical Sector," EconStor Open Access Book Chapters, in: Technological Innovations for Sustainability and Business Growth, pages 91-104, ZBW - Leibniz Information Centre for Economics.
    • Handle: RePEc:zbw:eschap:273742
    DOI: 10.4018/978-1-5225-9940-1.ch007
    as

    Download full text from publisher

    File URL: https://www.econstor.eu/bitstream/10419/273742/1/Innovations-Through-Mergers-and-Acquisitions-in-the-Pharmaceutical-Sector.pdf
    Download Restriction: no
    File URL: https://libkey.io/10.4018/978-1-5225-9940-1.ch007?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Heracleous, Loizos & Murray, John, 2001. "The urge to merge in the pharmaceutical industry," European Management Journal, Elsevier, vol. 19(4), pages 430-437, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ye Jin Lee & Kwangsoo Shin & Eungdo Kim, 2019. "The Influence of a Firm’s Capability and Dyadic Relationship of the Knowledge Base on Ambidextrous Innovation in Biopharmaceutical M&As," Sustainability, MDPI, vol. 11(18), pages 1-17, September.
    2. Pedro Domingos Antoniolli, 2016. "Information Technology Framework for Pharmaceutical Supply Chain Demand Management: a Brazilian Case Study," Brazilian Business Review, Fucape Business School, vol. 13(2), pages 27-55, March.
    3. Jeffrey Pfeffer & Christina T. Fong, 2005. "Building Organization Theory from First Principles: The Self-Enhancement Motive and Understanding Power and Influence," Organization Science, INFORMS, vol. 16(4), pages 372-388, August.
    4. Wei Teng, Chih & Foley, Lucy & O'Neill, Peter & Hicks, Chris, 2014. "An analysis of supply chain strategies in the regenerative medicine industry—Implications for future development," International Journal of Production Economics, Elsevier, vol. 149(C), pages 211-225.
    5. Katsaliaki, Korina & Kumar, Sameer & Loulos, Vasilis, 2024. "Supply chain coopetition: A review of structures, mechanisms and dynamics," International Journal of Production Economics, Elsevier, vol. 267(C).
    6. Park, Sungwook & Kwon, Youngsun, 2023. "Disentangling the effects on OTT platform performance of three strategies: Pricing, M&As, and content investments," Telecommunications Policy, Elsevier, vol. 47(8).

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:zbw:eschap:273742. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ZBW - Leibniz Information Centre for Economics (email available below). General contact details of provider: https://edirc.repec.org/data/zbwkide.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.